acc2151 |
p53 |
phosphorylation |
Ser15 |
human |
Ovarian Cancer |
A2780 |
Cisplatin |
Enhancing |
5.0 (High)
|
14513366
|
acc2152 |
p53 |
phosphorylation |
Ser15 |
human |
Breast Cancer |
MCF7 |
Cisplatin |
Enhancing |
5.0 (High)
|
14513366
|
acc2153 |
p53 |
phosphorylation |
Ser392 |
human |
Ovarian Cancer |
A2780 |
Cisplatin |
Enhancing |
5.0 (High)
|
14513366
|
acc2154 |
p53 |
phosphorylation |
Ser392 |
human |
Breast Cancer |
MCF7 |
Cisplatin |
Enhancing |
5.0 (High)
|
14513366
|
acc2155 |
p53 |
phosphorylation |
Ser15 |
human |
Ovarian Cancer |
2780CP/Cl-16 |
Cisplatin |
Enhancing |
5.0 (High)
|
14513366
|
acc2156 |
p53 |
phosphorylation |
Ser15 |
human |
Ovarian Cancer |
HEY/C-2 |
Cisplatin |
Enhancing |
5.0 (High)
|
14513366
|
acc2157 |
p53 |
phosphorylation |
Ser392 |
human |
Ovarian Cancer |
2780CP/Cl-16 |
Cisplatin |
Enhancing |
5.0 (High)
|
14513366
|
acc2158 |
p53 |
phosphorylation |
Ser392 |
human |
Ovarian Cancer |
HEY/C-2 |
Cisplatin |
Enhancing |
5.0 (High)
|
14513366
|
acc2159 |
ERK1 |
phosphorylation |
Thr202 |
human |
Lung Cancer |
PC9 |
Osimertinib |
Impairing |
5.0 (High)
|
34599981
|
acc2160 |
ERK1 |
phosphorylation |
Tyr204 |
human |
Lung Cancer |
PC9 |
Osimertinib |
Impairing |
5.0 (High)
|
34599981
|
acc2161 |
ERK2 |
phosphorylation |
Thr185 |
human |
Lung Cancer |
PC9 |
Osimertinib |
Impairing |
5.0 (High)
|
34599981
|
acc2162 |
ERK2 |
phosphorylation |
Tyr187 |
human |
Lung Cancer |
PC9 |
Osimertinib |
Impairing |
5.0 (High)
|
34599981
|
acc2163 |
PAX3-FOXO1 |
phosphorylation |
Ser201 |
human |
Sarcoma |
Rh30 |
LiCl |
Associated |
4.0 (Moderate) |
25821947
|
acc2164 |
PAX3-FOXO1 |
phosphorylation |
Ser205 |
human |
Sarcoma |
Rh30 |
LiCl |
Associated |
4.0 (Moderate) |
25821947
|
acc2165 |
PAX3-FOXO1 |
phosphorylation |
Ser201 |
human |
Sarcoma |
RH4 |
LiCl |
Associated |
4.0 (Moderate) |
25821947
|
acc2166 |
PAX3-FOXO1 |
phosphorylation |
Ser205 |
human |
Sarcoma |
RH4 |
LiCl |
Associated |
4.0 (Moderate) |
25821947
|
acc2167 |
PAX3-FOXO1 |
phosphorylation |
Ser201 |
human |
Sarcoma |
Rh30 |
AR-A014418 |
Associated |
4.0 (Moderate) |
25821947
|
acc2168 |
PAX3-FOXO1 |
phosphorylation |
Ser205 |
human |
Sarcoma |
Rh30 |
AR-A014418 |
Associated |
4.0 (Moderate) |
25821947
|
acc2169 |
PAX3-FOXO1 |
phosphorylation |
Ser201 |
human |
Sarcoma |
RH4 |
AR-A014418 |
Associated |
4.0 (Moderate) |
25821947
|
acc2170 |
PAX3-FOXO1 |
phosphorylation |
Ser205 |
human |
Sarcoma |
RH4 |
AR-A014418 |
Associated |
4.0 (Moderate) |
25821947
|
acc2171 |
PCK1 |
phosphorylation |
Ser90 |
human |
Hepatocellular Carcinoma |
HuH-7 |
MK-220 |
Associated |
4.0 (Moderate) |
32322062
|
acc2172 |
PCK1 |
phosphorylation |
Ser90 |
human |
Hepatocellular Carcinoma |
Hep3B |
MK-220 |
Associated |
4.0 (Moderate) |
32322062
|
acc2173 |
PELP1 |
phosphorylation |
Ser1033 |
human |
Breast Cancer |
MCF7 |
Etoposide |
Enhancing |
5.0 (High)
|
24786831
|
acc2174 |
PELP1 |
phosphorylation |
Ser1033 |
human |
Breast Cancer |
ZR75 |
Etoposide |
Enhancing |
5.0 (High)
|
24786831
|
acc2175 |
PELP1 |
phosphorylation |
Ser1033 |
human |
Breast Cancer |
MCF7 |
Camptothecin |
Enhancing |
5.0 (High)
|
24786831
|
acc2176 |
PELP1 |
phosphorylation |
Ser1033 |
human |
Breast Cancer |
ZR75 |
Camptothecin |
Enhancing |
5.0 (High)
|
24786831
|
acc2177 |
PELP1 |
phosphorylation |
Ser1033 |
human |
Breast Cancer |
MCF7 |
gamma-Radiation |
Enhancing |
4.5 (High)
|
24786831
|
acc2178 |
PELP1 |
phosphorylation |
Ser1033 |
human |
Breast Cancer |
ZR75 |
gamma-Radiation |
Enhancing |
4.5 (High)
|
24786831
|
acc2179 |
eIF2alpha |
phosphorylation |
Ser51 |
human |
Leukemia |
K562 |
Imatinib |
Impairing |
5.0 (High)
|
23095523
|
acc2180 |
eIF2alpha |
phosphorylation |
Ser51 |
human |
Leukemia |
BV173 |
Imatinib |
Impairing |
5.0 (High)
|
23095523
|
acc2181 |
PTEN |
phosphorylation |
Tyr240 |
human |
Glioma |
patient-derived glioma stem cell lines |
Ionising radiation |
Impairing |
4.5 (High)
|
31025173
|
acc2182 |
AMPKalpha1 |
phosphorylation |
Thr467 |
human |
Cervical Cancer |
Ishikawa |
SMI-4a + AICAR |
Associated |
4.0 (Moderate) |
31358902
|
acc2183 |
PKC |
phosphorylation |
Ser660 |
human |
Prostate Cancer |
LNCaP |
Ro-31-8220 |
Enhancing |
5.0 (High)
|
24352647
|
acc2184 |
PKC |
phosphorylation |
Ser660 |
human |
Prostate Cancer |
C4-2 |
Ro-31-8220 |
Enhancing |
5.0 (High)
|
24352647
|
acc2185 |
PKC |
phosphorylation |
Ser660 |
human |
Prostate Cancer |
22Rv1 |
Ro-31-8220 |
Enhancing |
5.0 (High)
|
24352647
|
acc2186 |
HSP27 |
phosphorylation |
Ser15 |
human |
Leukemia |
THP-1 |
Apigenin |
Enhancing |
5.0 (High)
|
21364669
|
acc2187 |
HSP27 |
phosphorylation |
Ser78 |
human |
Leukemia |
THP-1 |
Apigenin |
Enhancing |
5.0 (High)
|
21364669
|
acc2188 |
HSP27 |
phosphorylation |
Ser82 |
human |
Leukemia |
THP-1 |
Apigenin |
Enhancing |
5.0 (High)
|
21364669
|
acc2189 |
STAT1 |
phosphorylation |
Ser727 |
human |
Oral Cancer |
HSC-3 |
EGCG |
Associated |
4.0 (Moderate) |
19928918
|
acc2190 |
STAT1 |
phosphorylation |
Tyr701 |
human |
Oral Cancer |
HSC-3 |
EGCG |
Associated |
4.0 (Moderate) |
19928918
|
acc2191 |
JAK1 |
phosphorylation |
Tyr1022 |
human |
Oral Cancer |
HSC-3 |
EGCG |
Associated |
4.0 (Moderate) |
19928918
|
acc2192 |
JAK1 |
phosphorylation |
Tyr1023 |
human |
Oral Cancer |
HSC-3 |
EGCG |
Associated |
4.0 (Moderate) |
19928918
|
acc2193 |
JAK-2 |
phosphorylation |
Tyr1007 |
human |
Oral Cancer |
HSC-3 |
EGCG |
Associated |
4.0 (Moderate) |
19928918
|
acc2194 |
JAK-2 |
phosphorylation |
Tyr1008 |
human |
Oral Cancer |
HSC-3 |
EGCG |
Associated |
4.0 (Moderate) |
19928918
|
acc2195 |
PKCdelta |
phosphorylation |
Thr507 |
human |
Colorectal Cancer |
HT29 |
Magnolol |
Associated |
4.0 (Moderate) |
32429376
|
acc2196 |
PKCdelta |
phosphorylation |
Thr507 |
human |
Colorectal Cancer |
CT26 |
Magnolol |
Associated |
4.0 (Moderate) |
32429376
|
acc2197 |
AKT |
phosphorylation |
Ser473 |
human |
Colorectal Cancer |
HT29 |
Rottlerin |
Associated |
4.0 (Moderate) |
32429376
|
acc2198 |
AKT |
phosphorylation |
Ser473 |
human |
Colorectal Cancer |
CT26 |
Rottlerin |
Associated |
4.0 (Moderate) |
32429376
|
acc2199 |
NF-kappaB |
phosphorylation |
Ser276 |
human |
Colorectal Cancer |
HT29 |
Magnolol |
Associated |
4.0 (Moderate) |
32429376
|
acc2200 |
NF-kappaB |
phosphorylation |
Ser276 |
human |
Colorectal Cancer |
CT26 |
Magnolol |
Associated |
4.0 (Moderate) |
32429376
|